ROBERT C. KOSKI - 11 Dec 2025 Form 4 Insider Report for ORAGENICS INC (OGEN)

Role
Director
Signature
/s/ Julio C. Esquivel as Attorney-In-Fact for Robert Koski
Issuer symbol
OGEN
Transactions as of
11 Dec 2025
Net transactions value
$0
Form type
4
Filing time
15 Dec 2025, 16:19:51 UTC
Previous filing
13 Dec 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KOSKI ROBERT C Director 1990 MAIN STREET, SUITE 750, SARASOTA /s/ Julio C. Esquivel as Attorney-In-Fact for Robert Koski 15 Dec 2025 0001234880

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGEN Non-Employee Director Option (Right to Buy) Award $0 +125,000 $0.000000 125,000 11 Dec 2025 Common Stock 125,000 $0.9300 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.